ClinicalTrials.gg
RecruitingNCT06399705RECHARGE:MUpdated Sep 8, 2026

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

A Phase 3 interventional study of Coronary artery bypass grafting and Percutaneous coronary intervention in Coronary Artery Disease, sponsored by Weill Medical College of Cornell University. Recruiting at 18 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by Weill Medical College of Cornell University · Phase 3, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Coronary Artery Disease by Weill Medical College of Cornell University — 5 open to participants now, 5 under way, 2 of them phase 3. Coronary Artery Disease · Weill Medical College of Cornell University.

Started
2024
with 3 others
Phase 3
2 of 12
2 open now
Registered
9th of 12
by date

Among the 12 studies in Coronary Artery Disease by Weill Medical College of Cornell University, this one is one of 4 that started in 2024, is one of 2 in phase 3, and was the 9th registered.

Coronary Artery Disease

4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.

Browse Coronary Artery Disease studies →

Open to participants now

5 of the 12 studies in Coronary Artery Disease by Weill Medical College of Cornell University are open now, in 12 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Who these studies take

Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Coronary Artery Disease by Weill Medical College of Cornell University, or all of them as a file.
02

Study summary

This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an open-heart operation in which healthy blood vessels from inside the chest, leg, and/or forearm are used to "bypass" the blockages (like a detour). Outcomes will be measured by comparing survival and improvement in quality-of-life.

Read the detailed description

The RECHARGE: Minorities Trial is a multicenter, 1:1 randomized, open-label superiority trial.

Patients meeting the eligibility criteria for whom there is equipoise for revascularization with CABG and PCI, as determined by the local Heart Team, will be included. Participants will be followed for 5-10 years. Telephone follow-up will be conducted by the a central follow-up coordinating center at 30 days, 3 months, 6 months, and thereafter every 6 months through 36 months post-randomization. After 36 months, follow-up will be performed every year (48, 60, 72, 84, 96, 108, 120 months). A repeat transthoracic echocardiogram and blood draw for serum creatinine, hemoglobin and lipids should be performed at 1 year, as per standard of care, at either an out-patient facility or in a hospital.

03

Conditions studied

  • Coronary Artery Disease

Keywords

  • RECHARGE
  • Cardiac Surgery
  • Minority
  • percutaneous coronary intervention
  • Quality of Life
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patient must identify as Black race or Hispanic ethnicity
  2. Patient is at least 18 years old.
  3. Multivessel or left main CAD is present for which revascularization is intended and for which there is equipoise between CABG and PCI according to local Heart Team assessment.
  4. Ability to provide written and comply with all follow-up procedures, including QOL questionnaires.

Exclusion criteria

Exclusion Criteria:

  1. ST-segment elevation MI within 3 days
  2. Cardiogenic shock
  3. Prior PCI within 1 year or any prior CABG anytime
  4. Planned hybrid revascularization (PCI after CABG or CABG after PCI)
  5. Planned single vessel revascularization (other than isolated left main disease)
  6. Need for any cardiac surgical or interventional procedure other than coronary revascularization at the present time or anticipated within 3 years, with the exception that surgical or interventional left atrial appendage ligation or occlusion and/or atrial fibrillation ablation may be performed at site discretion either during or subsequent to the index revascularization procedure
  7. Pregnancy (women of must have a negative pregnancy test within 1 week before randomization) or intent to become pregnant within 1 year after randomization
  8. Unable to tolerate, obtain or comply with dual antiplatelet therapy for at least 3 months if presentation with stable CAD or 6 months if presentation with a troponin-positive acute coronary syndrome
  9. Current participation in another drug or device study that has not reached its primary endpoint
  10. Life-expectancy less than 3 years due to concomitant non-cardiac conditions
  11. Any condition(s) are present that are likely to interfere with the study protocol procedures including medication adherence and follow-up through 10 years (e.g. mental disability, substance abuse, anticipated international relocation, etc.)
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
600 participants (estimated)

Study arms

  • Other
    RECHARGE: Minorities - CABG

    Procedure: Coronary artery bypass grafting

  • Other
    RECHARGE: Minorities - PCI

    Procedure: Percutaneous coronary intervention

Interventions

  • ProcedureCoronary artery bypass grafting

    Coronary artery bypass grafting (CABG), also called heart bypass surgery, is a medical procedure to improve blood flow to the heart.

    Also known as: CABG

  • ProcedurePercutaneous coronary intervention

    Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat the blockages in a coronary artery; it opens up narrowed or blocked sections of the artery, restoring blood flow to the heart

    Also known as: PCI

06

What researchers measure

Primary outcomes

  1. Hierarchical composite of all-cause death and time-averaged change from baseline in generic quality of life using the SF-12v2

    Generic quality of life (QOL) will be assessed by utilizing the 12-item Short Form Survey (SF-12v2). The score ranges from 1-100, with higher scores indicating a better health status. The win ratio will be used

    Time frame: 5 years

Secondary outcomes

  1. Time averaged change from baseline in disease-specific quality of life using the SAQ-OS

    Disease-specific quality of life (QOL) will be assessed by utilizing the Seattle Angina Questionnaire overall summary (SAQ-OS) score. The score ranges from 1-100, with higher scores indicating a better health status.

    Time frame: 5 years

Other outcomes

  1. Time-averaged changes in PROMIS-29 Scores

    The PROMIS-29 instrument measures pain intensity on a scale of 0-10 plus 7 health domains: pain interference, fatigue, sleep disturbance, depressive symptoms, anxiety, physical function, and ability to participate in social roles. Each of the 7 domains is scored separately, with the lowest score for an individual domain being 4 and the highest being 20. Pain intensity is scored on the scale from 1-10. A mean of 50 and a standard deviation of 10 represent the general US population. A T-score rescales the raw scores to standardized scores. For most measures, higher T-scores indicate more of the concept being measured, except for physical function, which is reverse-scored (lower scores indicate worse function).

    Time frame: 1 month, 3months, 6months, 12months and annually after procedure

  2. Time-averaged changes in EQ5D-VAS Scores

    The EQ5D-VAS records self-rated health status on a graduated visual analog scale (VAS) from 0-100, with higher scores for higher health-related quality of life. It also includes the EQ-5D descriptive system, which comprises 5 dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems.

    Time frame: 1 month, 3months, 6months, 12months and annually after procedure

  3. Time-averaged changes in PHQ Scores

    The Patient Health Questionnaire (PHQ-8) is an 8-item questionnaire used to diagnose and quantify the severity of depressive symptoms. It is designed to evaluate the overall QOL of the individual and questions are based on the diagnostic criteria for Major Depressive Disorder outlined in the Diagnostic and Statistical Manual, 5th Edition (DSM-5). The lowest score is 0 and the highest score is 24. Scores ≥10 suggest a substantial burden of depressive symptoms.

    Time frame: 1 month, 3months, 6months, 12months and annually after procedure

  4. Time-averaged changes in MoCA scores

    The telephone Montreal Cognitive Assessment (MoCA Blind or T-MoCA) is a tool to assess mild cognitive impairment. The MoCA BlindT-MoCA consists of 15 non-visual items that assesses different cognitive domains, including attention and concentration, memory, language, conceptual thinking, calculations, and orientation. The maximum score is 22 points with a score of 18 or below signifying mild cognitive dysfunction.

    Time frame: 1 month, 3months, 6months, 12months and annually after procedure

  5. Number of days alive and out of hospital after procedure

    Time frame: up to 5 years after procedure

  6. Time to death

    Time frame: 1 month after procedure

  7. Time to death

    Time frame: 3 months after procedure

  8. Time to death

    Time frame: 6 months after procedure

  9. Time to death

    Time frame: 12 months after procedure

  10. Time to death

    Time frame: 18 months after procedure

  11. Time to death

    Time frame: 24 months after procedure

  12. Time to death

    Time frame: 30 months after procedure

  13. Time to death

    Time frame: 36 months after procedure

  14. Time to death

    Time frame: 48 months after procedure

  15. Time to death

    Time frame: 60 months after procedure

  16. Time to death

    Time frame: 72 months after procedure

  17. Time to death

    Time frame: 84 months after procedure

  18. Time to death

    Time frame: 96 months after procedure

  19. Time to death

    Time frame: 108 months after procedure

  20. Time to death

    Time frame: 120 months after procedure

  21. Time to cardiovascular death

    Time frame: 1 month after procedure

  22. Time to cardiovascular death

    Time frame: 3 months after procedure

  23. Time to cardiovascular death

    Time frame: 6 months after procedure

  24. Time to cardiovascular death

    Time frame: 12 months after procedure

  25. Time to cardiovascular death

    Time frame: 18 months after procedure

  26. Time to cardiovascular death

    Time frame: 24 months after procedure

  27. Time to cardiovascular death

    Time frame: 36 months after procedure

  28. Time to cardiovascular death

    Time frame: 48 months after procedure

  29. Time to cardiovascular death

    Time frame: 60 months after procedure

  30. Time to cardiovascular death

    Time frame: 72 months after procedure

  31. Time to cardiovascular death

    Time frame: 84 months after procedure

  32. Time to cardiovascular death

    Time frame: 96 months after procedure

  33. Time to cardiovascular death

    Time frame: 108 months after procedure

  34. Time to cardiovascular death

    Time frame: 120 months after procedure

  35. Time to non-cardiovascular death

    Time frame: 1 month after procedure

  36. Time to non-cardiovascular death

    Time frame: 3 months after procedure

  37. Time to non-cardiovascular death

    Time frame: 6 months after procedure

  38. Time to non-cardiovascular death

    Time frame: 12 months after procedure

  39. Time to non-cardiovascular death

    Time frame: 18 months after procedure

  40. Time to non-cardiovascular death

    Time frame: 24 months after procedure

  41. Time to non-cardiovascular death

    Time frame: 30 months after procedure

  42. Time to non-cardiovascular death

    Time frame: 36 months after procedure

  43. Time to non-cardiovascular death

    Time frame: 48 months after procedure

  44. Time to non-cardiovascular death

    Time frame: 60 months after procedure

  45. Time to non-cardiovascular death

    Time frame: 72 months after procedure

  46. Time to non-cardiovascular death

    Time frame: 84 months after procedure

  47. Time to non-cardiovascular death

    Time frame: 96 months after procedure

  48. Time to non-cardiovascular death

    Time frame: 108 months after procedure

  49. Time to non-cardiovascular death

    Time frame: 120 months after procedure

  50. Time to myocardial infarction

    Time frame: 1 month after procedure

  51. Time to myocardial infarction

    Time frame: 3 months after procedure

  52. Time to myocardial infarction

    Time frame: 6 months after procedure

  53. Time to myocardial infarction

    Time frame: 12 months after procedure

  54. Time to myocardial infarction

    Time frame: 18 months after procedure

  55. Time to myocardial infarction

    Time frame: 24 months after procedure

  56. Time to myocardial infarction

    Time frame: 30 months after procedure

  57. Time to myocardial infarction

    Time frame: 36 months after procedure

  58. Time to myocardial infarction

    Time frame: 48 months after procedure

  59. Time to myocardial infarction

    Time frame: 60 months after procedure

  60. Time to myocardial infarction

    Time frame: 72 months after procedure

  61. Time to myocardial infarction

    Time frame: 84 months after procedure

  62. Time to myocardial infarction

    Time frame: 96 months after procedure

  63. Time to myocardial infarction

    Time frame: 108 months after procedure

  64. Time to myocardial infarction

    Time frame: 120 months after procedure

  65. Time to stroke/transient ischemic attack

    Time frame: 1 month after procedure

  66. Time to stroke/transient ischemic attack

    Time frame: 3 months after procedure

  67. Time to stroke/transient ischemic attack

    Time frame: 6 months after procedure

  68. Time to stroke/transient ischemic attack

    Time frame: 12 months after procedure

  69. Time to stroke/transient ischemic attack

    Time frame: 18 months after procedure

  70. Time to stroke/transient ischemic attack

    Time frame: 24 months after procedure

  71. Time to stroke/transient ischemic attack

    Time frame: 30 months after procedure

  72. Time to stroke/transient ischemic attack

    Time frame: 36 months after procedure

  73. Time to stroke/transient ischemic attack

    Time frame: 48 months after procedure

  74. Time to stroke/transient ischemic attack

    Time frame: 60 months after procedure

  75. Time to stroke/transient ischemic attack

    Time frame: 72 months after procedure

  76. Time to stroke/transient ischemic attack

    Time frame: 84 months after procedure

  77. Time to stroke/transient ischemic attack

    Time frame: 96 months after procedure

  78. Time to stroke/transient ischemic attack

    Time frame: 108 months after procedure

  79. Time to stroke/transient ischemic attack

    Time frame: 120 months after procedure

  80. Time to hospitalization

    Time frame: 1 month after procedure

  81. Time to hospitalization

    Time frame: 3 months after procedure

  82. Time to hospitalization

    Time frame: 6 months after procedure

  83. Time to hospitalization

    Time frame: 12 months after procedure

  84. Time to hospitalization

    Time frame: 18 months after procedure

  85. Time to hospitalization

    Time frame: 24 months after procedure

  86. Time to hospitalization

    Time frame: 30 months after procedure

  87. Time to hospitalization

    Time frame: 36 months after procedure

  88. Time to hospitalization

    Time frame: 48 months after procedure

  89. Time to hospitalization

    Time frame: 60 months after procedure

  90. Time to hospitalization

    Time frame: 72 months after procedure

  91. Time to hospitalization

    Time frame: 84 months after procedure

  92. Time to hospitalization

    Time frame: 96 months after procedure

  93. Time to hospitalization

    Time frame: 108 months after procedure

  94. Time to hospitalization

    Time frame: 120 months after procedure

  95. Time to unplanned revascularization

    Time frame: 1 month after procedure

  96. Time to unplanned revascularization

    Time frame: 3 months after procedure

  97. Time to unplanned revascularization

    Time frame: 6 months after procedure

  98. Time to unplanned revascularization

    Time frame: 12 months after procedure

  99. Time to unplanned revascularization

    Time frame: 18 months after procedure

  100. Time to unplanned revascularization

    Time frame: 24 months after procedure

  101. Time to unplanned revascularization

    Time frame: 30 months after procedure

  102. Time to unplanned revascularization

    Time frame: 36 months after procedure

  103. Time to unplanned revascularization

    Time frame: 48 months after procedure

  104. Time to unplanned revascularization

    Time frame: 60 months after procedure

  105. Time to unplanned revascularization

    Time frame: 72 months after procedure

  106. Time to unplanned revascularization

    Time frame: 84 months after procedure

  107. Time to unplanned revascularization

    Time frame: 96 months after procedure

  108. Time to unplanned revascularization

    Time frame: 108 months after procedure

  109. Time to unplanned revascularization

    Time frame: 120 months after procedure

  110. Time to atrial fibrillation/ atrial flutter

    Time frame: 1 month after procedure

  111. Time to atrial fibrillation/ atrial flutter

    Time frame: 3 months after procedure

  112. Time to atrial fibrillation/ atrial flutter

    Time frame: 6 months after procedure

  113. Time to atrial fibrillation/ atrial flutter

    Time frame: 12 months after procedure

  114. Time to atrial fibrillation/ atrial flutter

    Time frame: 18 months after procedure

  115. Time to atrial fibrillation/ atrial flutter

    Time frame: 24 months after procedure

  116. Time to atrial fibrillation/ atrial flutter

    Time frame: 30 months after procedure

  117. Time to atrial fibrillation/ atrial flutter

    Time frame: 36 months after procedure

  118. Time to atrial fibrillation/ atrial flutter

    Time frame: 48 months after procedure

  119. Time to atrial fibrillation/ atrial flutter

    Time frame: 60 months after procedure

  120. Time to atrial fibrillation/ atrial flutter

    Time frame: 72 months after procedure

  121. Time to atrial fibrillation/ atrial flutter

    Time frame: 84 months after procedure

  122. Time to atrial fibrillation/ atrial flutter

    Time frame: 96 months after procedure

  123. Time to atrial fibrillation/ atrial flutter

    Time frame: 108 months after procedure

  124. Time to atrial fibrillation/ atrial flutter

    Time frame: 120 months after procedure

  125. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 1 month after procedure

  126. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 3 months after procedure

  127. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 6 months after procedure

  128. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 12 months after procedure

  129. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 18 months after procedure

  130. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 24 months after procedure

  131. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 30 months after procedure

  132. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 36 months after procedure

  133. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 48 months after procedure

  134. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 60 months after procedure

  135. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 72 months after procedure

  136. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 84 months after procedure

  137. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 96 months after procedure

  138. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 108 months after procedure

  139. Time to ventricular tachycardia/ventricular fibrillation

    Time frame: 120 months after procedure

  140. Time to heart block

    Time frame: 1 month after procedure

  141. Time to heart block

    Time frame: 3 months after procedure

  142. Time to heart block

    Time frame: 6 months after procedure

  143. Time to heart block

    Time frame: 12 months after procedure

  144. Time to heart block

    Time frame: 18 months after procedure

  145. Time to heart block

    Time frame: 24 months after procedure

  146. Time to heart block

    Time frame: 30 months after procedure

  147. Time to heart block

    Time frame: 36 months after procedure

  148. Time to heart block

    Time frame: 48 months after procedure

  149. Time to heart block

    Time frame: 60 months after procedure

  150. Time to heart block

    Time frame: 72 months after procedure

  151. Time to heart block

    Time frame: 84 months after procedure

  152. Time to heart block

    Time frame: 96 months after procedure

  153. Time to heart block

    Time frame: 108 months after procedure

  154. Time to heart block

    Time frame: 120 months after procedure

  155. Time to bleeding

    Time frame: 1 month after procedure

  156. Time to bleeding

    Time frame: 3 months after procedure

  157. Time to bleeding

    Time frame: 6 months after procedure

  158. Time to bleeding

    Time frame: 12 months after procedure

  159. Time to bleeding

    Time frame: 18 months after procedure

  160. Time to bleeding

    Time frame: 24 months after procedure

  161. Time to bleeding

    Time frame: 30 months after procedure

  162. Time to bleeding

    Time frame: 36 months after procedure

  163. Time to bleeding

    Time frame: 48 months after procedure

  164. Time to bleeding

    Time frame: 60 months after procedure

  165. Time to bleeding

    Time frame: 72 months after procedure

  166. Time to bleeding

    Time frame: 84 months after procedure

  167. Time to bleeding

    Time frame: 96 months after procedure

  168. Time to bleeding

    Time frame: 108 months after procedure

  169. Time to bleeding

    Time frame: 120 months after procedure

  170. Time to vascular complications

    Time frame: 1 month after procedure

  171. Time to vascular complications

    Time frame: 3 months after procedure

  172. Time to vascular complications

    Time frame: 6 months after procedure

  173. Time to vascular complications

    Time frame: 12 months after procedure

  174. Time to vascular complications

    Time frame: 18 months after procedure

  175. Time to vascular complications

    Time frame: 24 months after procedure

  176. Time to vascular complications

    Time frame: 30 months after procedure

  177. Time to vascular complications

    Time frame: 36 months after procedure

  178. Time to vascular complications

    Time frame: 48 months after procedure

  179. Time to vascular complications

    Time frame: 60 months after procedure

  180. Time to vascular complications

    Time frame: 72 months after procedure

  181. Time to vascular complications

    Time frame: 84 months after procedure

  182. Time to vascular complications

    Time frame: 96 months after procedure

  183. Time to vascular complications

    Time frame: 108 months after procedure

  184. Time to vascular complications

    Time frame: 120 months after procedure

  185. Time to heart failure

    Time frame: 1 month after procedure

  186. Time to heart failure

    Time frame: 3 months after procedure

  187. Time to heart failure

    Time frame: 6 months after procedure

  188. Time to heart failure

    Time frame: 12 months after procedure

  189. Time to heart failure

    Time frame: 18 months after procedure

  190. Time to heart failure

    Time frame: 24 months after procedure

  191. Time to heart failure

    Time frame: 30 months after procedure

  192. Time to heart failure

    Time frame: 36 months after procedure

  193. Time to heart failure

    Time frame: 48 months after procedure

  194. Time to heart failure

    Time frame: 60 months after procedure

  195. Time to heart failure

    Time frame: 72 months after procedure

  196. Time to heart failure

    Time frame: 84 months after procedure

  197. Time to heart failure

    Time frame: 96 months after procedure

  198. Time to heart failure

    Time frame: 108 months after procedure

  199. Time to heart failure

    Time frame: 120 months after procedure

  200. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 1 month after procedure

  201. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 3 months after procedure

  202. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 6 months after procedure

  203. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 12 months after procedure

  204. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 18 months after procedure

  205. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 24 months after procedure

  206. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 30 months after procedure

  207. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 36 months after procedure

  208. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 48 months after procedure

  209. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 60 months after procedure

  210. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 72 months after procedure

  211. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 84 months after procedure

  212. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 96 months after procedure

  213. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 108 months after procedure

  214. Time to left ventricular assist device/orthotopic heart transplant

    Time frame: 120 months after procedure

  215. Time to infection

    Time frame: 1 month after procedure

  216. Time to infection

    Time frame: 3 months after procedure

  217. Time to infection

    Time frame: 6 months after procedure

  218. Time to infection

    Time frame: 12 months after procedure

  219. Time to infection

    Time frame: 18 months after procedure

  220. Time to infection

    Time frame: 24 months after procedure

  221. Time to infection

    Time frame: 30 months after procedure

  222. Time to infection

    Time frame: 36 months after procedure

  223. Time to infection

    Time frame: 48 months after procedure

  224. Time to infection

    Time frame: 60 months after procedure

  225. Time to infection

    Time frame: 72 months after procedure

  226. Time to infection

    Time frame: 84 months after procedure

  227. Time to infection

    Time frame: 96 months after procedure

  228. Time to infection

    Time frame: 108 months after procedure

  229. Time to infection

    Time frame: 120 months after procedure

  230. Time to acute kidney injury/chronic kidney disease

    Time frame: 1 month after procedure

  231. Time to acute kidney injury/chronic kidney disease

    Time frame: 3 months after procedure

  232. Time to acute kidney injury/chronic kidney disease

    Time frame: 6 months after procedure

  233. Time to acute kidney injury/chronic kidney disease

    Time frame: 12 months after procedure

  234. Time to acute kidney injury/chronic kidney disease

    Time frame: 18 months after procedure

  235. Time to acute kidney injury/chronic kidney disease

    Time frame: 24 months after procedure

  236. Time to acute kidney injury/chronic kidney disease

    Time frame: 30 months after procedure

  237. Time to acute kidney injury/chronic kidney disease

    Time frame: 36 months after procedure

  238. Time to acute kidney injury/chronic kidney disease

    Time frame: 48 months after procedure

  239. Time to acute kidney injury/chronic kidney disease

    Time frame: 60 months after procedure

  240. Time to acute kidney injury/chronic kidney disease

    Time frame: 72 months after procedure

  241. Time to acute kidney injury/chronic kidney disease

    Time frame: 84 months after procedure

  242. Time to acute kidney injury/chronic kidney disease

    Time frame: 96 months after procedure

  243. Time to acute kidney injury/chronic kidney disease

    Time frame: 108 months after procedure

  244. Time to acute kidney injury/chronic kidney disease

    Time frame: 120 months after procedure

  245. Number of subjects with complete revascularization

    Time frame: 30 days after procedure

  246. Number of subjects with reasonably complete revascularization

    Time frame: 30 days after procedure

  247. Change in blood lipids

    Time frame: Baseline, 12 months post-procedure

  248. Change in hemoglobin

    Time frame: Baseline, 12 months post-procedure

  249. Change in LVEF

    Time frame: Baseline, 12 months post-procedure

07

Study locations

18 of 18 sites recruiting
08

References and documents

Publications

  • Gaudino M, Stone GW, Puskas J, Krieger K, Redfors B, Bagiella E, Gelijns A, Bhatt DL, Sandner S, Barman N, Bozinovski J, Gee P, Haider A, Hafiz AM, Jolly SS, Li D, Mack C, Madani MM, Mahmud E, Pineda AM, Masoudi FA, Mazzaferri E, Monroe R, Nicholson W, Pocock SJ, Sachdeva R, Yong C, Zwischenberger BA, Yancy C, Creber RM, Spertus J. Lessons learned from the feasibility phase of the REvascularization CHoices Among Under-Represented Groups Evaluation (RECHARGE) trial program. Am Heart J. 2026 Jun 20;301:107515. doi: 10.1016/j.ahj.2026.107515. Online ahead of print. PubMed 42323001 ↗
  • Nino de Rivera S, Suero-Tejeda NM, Monroe R, Tang M, Eslami S, Sallam A, Gee PO, Redfors B, Yancy CW, Gaudino MFL, Stone GW, Spertus JA, Masterson Creber RM. Patient Perspectives in Cardiovascular Research: A Qualitative Study of Barriers, Trust, and Strategies for Inclusive Clinical Trials. Circ Popul Health Outcomes. 2026 Jul;19(7):e012189. doi: 10.1161/CIRCOUTCOMES.125.012189. Epub 2026 Jun 12. PubMed 42283075 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Mar 2033, 101 months after the start.

Of 62 phase 3 interventional studies under Coronary Artery Disease, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 58. This study's planned 101 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2024
First posted
May 6, 2024
StartActual
Oct 2, 2024
Primary completionEst.
Mar 15, 2033
CompletionEst.
Jan 1, 2039
Last update
Sep 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06399705
Collaborators
Patient-Centered Outcomes Research Institute, Icahn School of Medicine at Mount Sinai
Responsible party
Sponsor
First posted
May 6, 2024
Start date
Oct 2, 2024
Primary completion
Mar 15, 2033 (estimated)
Completion
Jan 1, 2039 (estimated)
Last update
Sep 8, 2026

Study contacts

Mario Gaudino, MD, PhD, MSCE, FEBCTS, FACC
Contact
mfg9004@med.cornell.edu
Gregg.Stone@mountsinai.org
Gregg Stone, MD, FACC, MSCAI
Contact
Gregg.Stone@mountsinai.org
Mario Gaudino, MD, PhD, MSCE, FEBCTS, FACC
principal investigator · Weill Medical College of Cornell University
Gregg Stone, MD, FACC, MSCAI
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion